Clene Provides Update On Its NIH-Funded Expanded Access Program For CNM-Au8® In ALS (ACT-EAP)
National Institutes Of Health United States Salt Lake City Kevin Gardner Jinsya Andrews David Schull
Source: menafn.com
📰 David Schull News
David Schull News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Schull. Real-time updates on events, politics, business and more.
Spectral AI Announces Purchases of Over 100,000 Shares by Insiders
DALLAS, May 17, 2024 -- Spectral AI, Inc. , an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that...
Source: marketscreener.com
Spectral AI Awarded Quality Achievement Award from the Texas Manufacturer Assistance Center
DALLAS, April 30, 2024 -- Spectral AI, Inc. , an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced...
Source: marketscreener.com
Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary
Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholdersDALLAS, April 24, 2024 -- Spectral AI, Inc. , an artificial...
Source: marketscreener.com
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
22.04.2024 - The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ETCORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage ...
United States David Schull Mary Coleman Catalyst Pharmaceuticals Inc Exchange Commission Health Canada
Source: wallstreet-online.de
BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer's Dementia -April 10, 2024 at 07:01 am EDT
Company plans to initiate trial following recent meeting with FDA No FDA-approved therapies for acute treatment of AAD are currently available NEW HAVEN, Conn., April 10, 2024 -- BioXcel...
Source: marketscreener.com
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
Experienced Burn Industry Executive Champions Pivot to CommercializationDALLAS, April 01, 2024 -- Spectral AI, Inc. , an artificial intelligence company focused on medical diagnostics for faster...
Source: marketscreener.com
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living
Source: eagletribune.com
Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results
2023 Research & Development Revenue of $18.1 Million Expected to Increase to $28.0 Million in 2024 Commercialization Underway with Revenue Expected in 2H 2024 for DeepView AI®-Burn Indication in...
Source: marketscreener.com
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and ...
Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022
Source: eagletribune.com